OTCMKTS:MKKGY - MERCK Kommanditgesellschaft auf Aktien Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 4 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$44.28
▼ -1.35 (-2.96%)

This chart shows the closing price for MKKGY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New MERCK Kommanditgesellschaft auf Aktien Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MKKGY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MKKGY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 8 analysts offering 12 month price targets for MERCK Kommanditgesellschaft auf Aktien in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $44.28.

This chart shows the closing price for MKKGY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 8 polled investment analysts is to hold stock in MERCK Kommanditgesellschaft auf Aktien. This rating has held steady since November 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
4/5/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/4/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/2/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 1 sell ratings
12/31/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 1 sell ratings
3/31/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings
6/29/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings
8/28/2021
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings
9/27/2021

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
9/17/2021Morgan StanleyReiterated RatingEqual Weight
9/14/2021UBS GroupDowngradeNeutral ➝ Sell
9/13/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
9/10/2021JPMorgan Chase & Co.Reiterated RatingOverweight
9/2/2021BarclaysReiterated RatingEqual Weight
8/10/2021Morgan StanleyReiterated RatingEqual Weight
8/9/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
8/6/2021JPMorgan Chase & Co.Reiterated RatingOverweight
8/6/2021Credit Suisse GroupReiterated RatingOutperform
8/6/2021Societe GeneraleReiterated RatingHold
6/1/2021Berenberg BankReiterated RatingHold
5/17/2021Deutsche Bank AktiengesellschaftReiterated RatingBuy
5/13/2021JPMorgan Chase & Co.Reiterated RatingOverweight
3/8/2021Morgan StanleyReiterated RatingEqual Weight
2/10/2021BarclaysReiterated RatingEqual Weight
2/5/2021Morgan StanleyReiterated RatingEqual Weight
1/8/2021Morgan StanleyReiterated RatingEqual Weight
11/17/2020UBS GroupReiterated RatingNeutral
11/16/2020Morgan StanleyReiterated RatingEqual Weight
11/13/2020BarclaysReiterated RatingEqual Weight
10/30/2020Morgan StanleyReiterated RatingEqual Weight
9/17/2020Credit Suisse GroupReiterated RatingOutperform
9/15/2020JPMorgan Chase & Co.Reiterated RatingNeutral
9/14/2020Morgan StanleyReiterated RatingEqual Weight
5/5/2020Deutsche Bank AktiengesellschaftReiterated RatingHold
5/5/2020BarclaysReiterated RatingUnderweight
5/4/2020Morgan StanleyReiterated RatingEqual Weight
6/28/2019Bank of AmericaReiterated RatingNeutral ➝ Underperform
4/9/2019Sanford C. BernsteinReiterated RatingOutperform ➝ Mkt Perform
3/15/2019UBS GroupReiterated RatingBuy ➝ Neutral
10/29/2018Credit Suisse GroupUpgradeNeutral ➝ Outperform
5/25/2018DZ BankReiterated RatingNeutral
9/26/2017UBS GroupInitiated CoverageBuy ➝ Buy
(Data available from 9/28/2016 forward)

News Sentiment Rating

0.08 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/2/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/1/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/1/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/31/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/30/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/30/2021
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/29/2021
  • 1 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/28/2021

Current Sentiment

  • 1 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
MERCK Kommanditgesellschaft auf Aktien logo
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, Performance Materials and Corporate and Other. The Healthcare sector discovers, develops, and produces prescription medicines used to treat cancer, multiple sclerosis, and infertility. The Life Science sector provides scientists with laboratory materials, technologies, and services. The Performance Materials sector offers specialty chemicals and materials for demanding applications. The firm offers pharma and biopharma manufacturing, pharmaceutical research, pharma quality control, and government and academic research services. The company was founded by Friedrich Jacob Merck in 1668 and is headquartered in Darmstadt, Germany.
Read More

Today's Range

Now: $44.28
Low: $44.12
High: $44.60

50 Day Range

MA: $45.26
Low: $39.64
High: $49.03

52 Week Range

Now: $44.28
Low: $28.87
High: $49.08

Volume

39,420 shs

Average Volume

51,733 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of MERCK Kommanditgesellschaft auf Aktien?

The following Wall Street sell-side analysts have issued research reports on MERCK Kommanditgesellschaft auf Aktien in the last year: Barclays PLC, Berenberg Bank, Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Morgan Stanley, Societe Generale, and UBS Group AG.
View the latest analyst ratings for MKKGY.

What is the current price target for MERCK Kommanditgesellschaft auf Aktien?

0 Wall Street analysts have set twelve-month price targets for MERCK Kommanditgesellschaft auf Aktien in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for MERCK Kommanditgesellschaft auf Aktien in the next year.
View the latest price targets for MKKGY.

What is the current consensus analyst rating for MERCK Kommanditgesellschaft auf Aktien?

MERCK Kommanditgesellschaft auf Aktien currently has 1 sell rating, 4 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in MKKGY, but not buy more shares or sell existing shares.
View the latest ratings for MKKGY.

What other companies compete with MERCK Kommanditgesellschaft auf Aktien?

How do I contact MERCK Kommanditgesellschaft auf Aktien's investor relations team?

MERCK Kommanditgesellschaft auf Aktien's physical mailing address is Frankfurter Strasse 250, DARMSTADT, 64293, Germany. The company's listed phone number is 496151720. The official website for MERCK Kommanditgesellschaft auf Aktien is www.merckgroup.com.